BDTX - Black Diamond Therapeutics, Inc.

QQQ $ 455.25 $ 5.77 (1.29 %)

DIA $ 409.08 $ 4.58 (1.13 %)

SPY $ 546.60 $ 6.05 (1.12 %)

TLT $ 99.96 $ 0.43 (0.43 %)

GLD $ 231.58 $ 0.97 (0.42 %)

Previous Close

$ 5.66

Open

$ 5.39

Bid

$ 5.66 x 200

Ask

$ 5.67 x 199

Day's Range

$ 5.39 - $ 5.68

52 Week Range

$ 1.62 - $ 7.66

Volume

415,811

Average Volume

Market Cap

319.82M

Beta (5Y Monthly)

$ 1.70

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-12-2024	12-31-2023	10-K
4	11-06-2023	09-30-2023	10-Q
5	08-11-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	03-09-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-11-2022	03-31-2022	10-Q
11	03-17-2022	12-31-2021	10-K
12	11-08-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	05-07-2021	03-31-2021	10-Q
15	03-25-2021	12-31-2020	10-K
16	11-10-2020	09-30-2020	10-Q
17	08-11-2020	06-30-2020	10-Q
18	05-12-2020	03-31-2020	10-Q
19	03-24-2020	12-31-2019	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Blac...
09/04/2024 11:28:15

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11...

looking-into-black-diamond-therapeutics-recent-short-interest

Looking Into Black Diamond Therapeutic's R...
08/22/2024 13:15:16

Wedbush Reiterates Outperform on Black Dia...
08/07/2024 14:37:48

Wedbush analyst Robert Driscoll reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and maintains $16 price...

Black Diamond Therapeutics' Cash, Cash Equ...
08/06/2024 11:45:38

Black Diamond Therapeutic Q2 2024 GAAP EPS...
08/06/2024 11:44:50

Raymond James Initiates Coverage On Black ...
07/31/2024 09:42:17

Raymond James analyst Laura Prendergast initiates coverage on Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform rati...

Piper Sandler Maintains Overweight on Blac...
07/03/2024 16:28:18

Piper Sandler analyst Joseph Catanzaro maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Overweight and maintains $12...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
06/11/2024 16:31:11

HC Wainwright & Co. Reiterates Buy on Blac...
06/07/2024 11:17:50

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11...

Reported Saturday, Black Diamond Therapeut...
06/03/2024 07:47:08

Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profil...

HC Wainwright & Co. Maintains Buy on Black...
05/16/2024 11:36:42

HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and lowers the pri...

Black Diamond Therapeutics Expects Cash & ...
05/09/2024 12:12:51

Black Diamond Therapeutic Q1 2024 GAAP EPS...
05/09/2024 12:11:44

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimat...

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
04/23/2024 20:31:12

Wedbush Maintains Outperform on Black Diam...
04/08/2024 15:18:17

Wedbush analyst Robert Driscoll maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and raises the price tar...

Black Diamond Therapeutics Presented Novel...
04/08/2024 06:15:24

Real-world data demonstrate non-classical mutations are present in 20-30% of all patients with EGFRm NSCLC Emerging data sho...

HC Wainwright & Co. Reiterates Buy on Blac...
03/18/2024 10:46:13

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and raises the pr...

Wedbush Reiterates Outperform on Black Dia...
03/13/2024 13:40:43

Wedbush analyst Robert Driscoll reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and maintains $10 price...

Black Diamond Therapeutic: Q4 Earnings Ins...
03/12/2024 21:05:23

Black Diamond Therapeutic Q4 EPS $(0.34) B...
03/12/2024 12:11:22

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimat...